ERBB2 and neoplasm: While we tried to correlate the ARM identification rate with BMI, T and N stage of disease, location of tumor, ER/PR, HER2/neu status, and NACT status systematically, which were not well evaluated in previous studies, a relatively small sample size and heterogeneous population were limitations of our study.